Trade Raffles Medical - BSLsg CFD

Add to favourite

0.9968

0.99%

0.0164

Low: 0.9968

High: 1.0068

Market Trading Hours* (UTC) Open now
Closes on Tuesday at 09:00

Mon - Fri: 01:00 - 04:00 05:00 - 09:00

Summary
Historical Data
Events
Income Statement
Balance Sheet
Cash Flow

Trading сonditions

Spread

0.0164

Long position overnight fee

-0.020345%

Short position overnight fee

-0.001573%

Overnight fee time

21:00 (UTC)

Min traded quantity

Currency

SGD

Margin

Stock exchange

Singapore

Commission on trade

*Information provided by Capital.com

Raffles Medical Group Ltd ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats

Prev. Close*	1.0068
Open*	0.9968
1-Year Change*	-32.44%
Day's Range*	0.9968 - 1.0068
52 wk Range	1.01-1.52
Average Volume (10 days)	806.46K
Average Volume (3 months)	37.52M
Market Cap	1.96B
P/E Ratio	13.51
Shares Outstanding	1.86B
Revenue	755.08M
EPS	0.08
Dividend (Yield %)	3.65385
Beta	0.77
Next Earnings Date	Feb 26, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Apr 22, 2024	0.9968	0.0000	0.00%	0.9968	1.0068	0.9968
Apr 19, 2024	1.0068	0.0100	1.00%	0.9968	1.0168	0.9968
Apr 18, 2024	0.9968	0.0049	0.49%	0.9919	0.9968	0.9918
Apr 17, 2024	0.9968	0.0049	0.49%	0.9919	0.9968	0.9919
Apr 16, 2024	0.9968	0.0049	0.49%	0.9919	0.9968	0.9918
Apr 15, 2024	0.9968	0.0049	0.49%	0.9919	0.9968	0.9918
Apr 12, 2024	0.9968	-0.0200	-1.97%	1.0168	1.0168	0.9968
Apr 11, 2024	1.0068	-0.0100	-0.98%	1.0168	1.0168	1.0068
Apr 9, 2024	1.0168	0.0200	2.01%	0.9968	1.0168	0.9968
Apr 8, 2024	1.0068	-0.0100	-0.98%	1.0168	1.0168	0.9918
Apr 5, 2024	1.0068	-0.0199	-1.94%	1.0267	1.0267	1.0068
Apr 4, 2024	1.0367	-0.0100	-0.96%	1.0467	1.0567	1.0367
Apr 3, 2024	1.0567	0.0100	0.96%	1.0467	1.0567	1.0467
Apr 2, 2024	1.0467	0.0200	1.95%	1.0267	1.0467	1.0267
Apr 1, 2024	1.0367	0.0100	0.97%	1.0267	1.0367	1.0267
Mar 28, 2024	1.0267	0.0000	0.00%	1.0267	1.0367	1.0267
Mar 27, 2024	1.0467	0.0000	0.00%	1.0467	1.0467	1.0467
Mar 26, 2024	1.0367	0.0100	0.97%	1.0267	1.0367	1.0168
Mar 25, 2024	1.0168	0.0000	0.00%	1.0168	1.0267	1.0168
Mar 22, 2024	1.0267	0.0099	0.97%	1.0168	1.0267	1.0168

Raffles Medical Events

Time (UTC)	Country	Event
Friday, April 26, 2024
Time (UTC) 07:30	Country SG	Event Raffles Medical Group Ltd Annual Shareholders Meeting Raffles Medical Group Ltd Annual Shareholders Meeting Forecast - Previous -
Time (UTC) 07:30	Country SG	Event Raffles Medical Group Ltd Annual Shareholders Meeting Raffles Medical Group Ltd Annual Shareholders Meeting Forecast - Previous -
Monday, May 13, 2024
Time (UTC) 12:00	Country SG	Event Raffles Medical Group Ltd Raffles Medical Group Ltd Forecast - Previous -
Monday, July 29, 2024
Time (UTC) 00:30	Country SG	Event Half Year 2024 Raffles Medical Group Ltd Earnings Release Half Year 2024 Raffles Medical Group Ltd Earnings Release Forecast - Previous -

View all events

Annual
Quarterly

	2022	2021	2020	2019	2018
Total revenue	766.537	723.791	568.203	522.038	489.135
Revenue	766.537	723.791	568.203	522.038	489.135
Cost of Revenue, Total	126.556	143.27	135.775	110.969	99.518
Gross Profit	639.981	580.521	432.428	411.069	389.617
Total Operating Expense	570.691	602.485	479.761	445.87	404.9
Selling/General/Admin. Expenses, Total	344.56	390.212	295.637	274.059	259.514
Depreciation / Amortization	40.216	39.326	35.495	29.26	18.273
Other Operating Expenses, Total	42.147	36.147	12.854	31.582	30.99
Operating Income	195.846	121.306	88.442	76.168	84.235
Interest Income (Expense), Net Non-Operating	-4.142	-5.722	-4.003	-0.244	-0.101
Net Income Before Taxes	191.704	115.584	84.439	75.924	84.134
Net Income After Taxes	143.702	83.716	64.67	60.522	70.803
Minority Interest	-0.186	0.455	1.221	-0.249	0.253
Net Income Before Extra. Items	143.516	84.171	65.891	60.273	71.056
Net Income	143.516	84.171	65.891	60.273	71.056
Income Available to Common Excl. Extra. Items	143.516	84.171	65.891	60.273	71.056
Income Available to Common Incl. Extra. Items	143.516	84.171	65.891	60.273	71.056
Diluted Net Income	143.516	84.171	65.891	60.273	71.056
Diluted Weighted Average Shares	1866.35	1876.46	1840.37	1815.81	1788.29
Diluted EPS Excluding Extraordinary Items	0.0769	0.04486	0.0358	0.03319	0.03973
Dividends per Share - Common Stock Primary Issue	0.038	0.018	0.025	0.025	0.025
Diluted Normalized EPS	0.0843	0.04433	0.03794	0.03326	0.04
Interest Expense (Income) - Net Operating					-3.395
Unusual Expense (Income)	17.212	-6.47

	Jun 2023	Dec 2022	Jun 2022	Dec 2021	Jun 2021
Total revenue	370.85	384.233	409.739	379.976	343.815
Revenue	370.85	384.233	409.739	379.976	343.815
Cost of Revenue, Total	92	65.467	77.057	72.129	71.141
Gross Profit	278.85	318.766	332.682	307.847	272.674
Total Operating Expense	294.184	274.764	323.517	314.733	287.752
Selling/General/Admin. Expenses, Total	163.291	146.85	197.71	205.197	185.015
Depreciation / Amortization	19.022	19.59	20.626	20.846	18.48
Interest Expense (Income) - Net Operating
Unusual Expense (Income)		17.296
Other Operating Expenses, Total	19.871	25.561	28.124	16.561	13.116
Operating Income	76.666	109.469	86.222	65.243	56.063
Interest Income (Expense), Net Non-Operating	1.76	-1.248	-2.894	-3.25	-2.472
Net Income Before Taxes	78.426	108.221	83.328	61.993	53.591
Net Income After Taxes	60.417	83.74	59.833	44.876	38.84
Minority Interest	-0.566	0.105	-0.291	-0.15	0.605
Net Income Before Extra. Items	59.851	83.845	59.542	44.726	39.445
Net Income	59.851	83.845	59.542	44.726	39.445
Income Available to Common Excl. Extra. Items	59.851	83.845	59.542	44.726	39.445
Income Available to Common Incl. Extra. Items	59.851	83.845	59.542	44.726	39.445
Diluted Net Income	59.851	83.845	59.542	44.726	39.445
Diluted Weighted Average Shares	1870.14	1863.62	1869.07	1882.52	1870.4
Diluted EPS Excluding Extraordinary Items	0.032	0.04499	0.03186	0.02376	0.02109
Dividends per Share - Common Stock Primary Issue	0	0.038	0	0.018	0
Diluted Normalized EPS	0.03206	0.05266	0.03188	0.02425	0.01858

Annual
Quarterly

	2022	2021	2020	2019	2018
Total Current Assets	460.257	439.099	331.13	246.006	198.525
Cash and Short Term Investments	253.127	264.988	203.114	151.826	105.984
Cash & Equivalents
Total Receivables, Net	194.032	160.737	113.429	83.935	83.221
Accounts Receivable - Trade, Net	194.032	160.737	113.429	83.935	83.221
Total Inventory	13.098	13.374	14.587	10.245	9.32
Total Assets	1497.7	1545.29	1404.13	1284.82	1116.29
Property/Plant/Equipment, Total - Net	739.072	797.362	739.905	685.585	565.716
Property/Plant/Equipment, Total - Gross	908.471	959.927	879.784	819.76	674.788
Accumulated Depreciation, Total	-169.399	-162.565	-139.879	-134.175	-109.072
Goodwill, Net	11.15	18.322	21.233	23.835	24.423
Intangibles, Net	9.124	13.508	12.911	13.619	12.864
Long Term Investments	273.4	274	294.6	311.16	311.16
Note Receivable - Long Term	2.274	1.857	3.285	3.452	2.59
Other Long Term Assets, Total	2.425	1.138	1.07	1.165	1.011
Total Current Liabilities	325.7	416.611	279.924	218.953	186.329
Payable/Accrued	223.771	253.568	191.382	162.53	136.789
Notes Payable/Short Term Debt	0	0	0	0	0
Current Port. of LT Debt/Capital Leases	19.326	106.54	38.736	19.301	19.307
Other Current Liabilities, Total	82.603	56.503	49.806	37.122	30.233
Total Liabilities	482.648	584.492	505.138	443.929	315.8
Total Long Term Debt	76.817	91.592	166.157	181.075	97.189
Long Term Debt	63.376	77.914	143.859	156.559	97.189
Deferred Income Tax	8.303	10.147	7.746	7.014	4.765
Minority Interest	15.35	15.826	15.401	15.961	16.137
Other Liabilities, Total	56.478	50.316	35.91	20.926	11.38
Total Equity	1015.05	960.794	898.996	840.893	800.489
Common Stock	432.379	426.346	420.966	393.47	365.332
Retained Earnings (Accumulated Deficit)	606.22	512.222	463.172	441.519	424.921
Unrealized Gain (Loss)	16.367	16.367	16.367	16.367	16.367
Other Equity, Total	-13.018	9.089	-1.109	-10.063	-6.131
Total Liabilities & Shareholders’ Equity	1497.7	1545.29	1404.13	1284.82	1116.29
Total Common Shares Outstanding	1854.55	1868.29	1864.73	1827.94	1797.17
Cash	83.159	99.152	44.753	52.108	61.406
Short Term Investments	169.968	165.836	158.361	99.718	44.578
Capital Lease Obligations	13.441	13.678	22.298	24.516
Treasury Stock - Common	-26.894	-3.23	-0.4	-0.4

	Jun 2023	Dec 2022	Jun 2022	Dec 2021	Jun 2021
Total Current Assets	503.907	460.257	432.309	439.099	358.517
Cash and Short Term Investments	300.695	253.127	289.067	264.988	215.741
Cash & Equivalents	300.695	253.127	289.067	264.988	215.741
Total Receivables, Net	190.298	194.032	130.682	160.737	128.279
Accounts Receivable - Trade, Net	190.298	194.032	130.682	160.737	128.279
Total Inventory	12.914	13.098	12.56	13.374	14.497
Total Assets	1522.81	1497.7	1518.86	1545.29	1455.09
Property/Plant/Equipment, Total - Net	720.022	739.072	777.775	797.362	763.52
Intangibles, Net	7.987	9.124	12.136	31.83	35.132
Long Term Investments	273.4	273.4	274	274	294.6
Note Receivable - Long Term	2.348	2.274	3.313	1.857	2.172
Other Long Term Assets, Total	4.3	2.425	1.243	1.138	1.147
Total Current Liabilities	414.694	325.7	404.253	416.611	318.25
Payable/Accrued	260.517	223.771	243.622	253.568	207.487
Notes Payable/Short Term Debt	87.656	0	0	0	0
Current Port. of LT Debt/Capital Leases	21.4	19.326	86.224	106.54	49.177
Other Current Liabilities, Total	45.121	82.603	74.407	56.503	61.586
Total Liabilities	523.871	482.648	573.114	584.492	544.256
Total Long Term Debt	71.594	76.817	89.623	91.592	162.65
Long Term Debt	60.312	63.376	77.914	77.914	145.036
Capital Lease Obligations	11.282	13.441	11.709	13.678	17.614
Deferred Income Tax	9.418	8.303	10.615	10.147	7.68
Minority Interest	15.747	15.35	16.093	15.826	15.358
Other Liabilities, Total	12.418	56.478	52.53	50.316	40.318
Total Equity	998.941	1015.05	945.745	960.794	910.832
Common Stock	438.623	432.379	430.777	426.346	423.176
Retained Earnings (Accumulated Deficit)	594.613	606.22	521.306	512.222	466.228
Treasury Stock - Common	-26.894	-26.894	-26.787	-3.23	0
Unrealized Gain (Loss)	16.367	16.367	16.367	16.367	16.367
Other Equity, Total	-23.768	-13.018	4.082	9.089	5.061
Total Liabilities & Shareholders’ Equity	1522.81	1497.7	1518.86	1545.29	1455.09
Total Common Shares Outstanding	1860.33	1854.55	1852.44	1868.29	1867.56
Goodwill, Net	10.848	11.15	18.083

Annual
Quarterly

	2022	2021	2020	2019	2018
Net income/Starting Line	143.702	83.716	64.67	60.522	70.803
Cash From Operating Activities	196.225	160.112	133.146	111.147	91.528
Cash From Operating Activities	37.513	36.725	33.487	27.65	17.172
Amortization	2.703	2.601	2.008	1.61	1.101
Non-Cash Items	74.315	44.642	34.985	15.06	12.069
Cash Taxes Paid	29.146	21.742	9.705	12.488	12.694
Cash Interest Paid	6.796	7.305	6.025	4.857	2.03
Changes in Working Capital	-62.008	-7.572	-2.004	6.305	-9.617
Cash From Investing Activities	-22.832	-52.199	-62.189	-96.871	-102.656
Capital Expenditures	-25.299	-52.804	-60.064	-98.379	-31.407
Other Investing Cash Flow Items, Total	2.467	0.605	-2.125	1.508	-71.249
Cash From Financing Activities	-183.702	-46.873	-20.878	31.547	20.076
Financing Cash Flow Items	-6.796	-7.305	-6.025	-4.857	-2.413
Total Cash Dividends Paid	-52.015	-37.349	-19.186	-17.954	-15.63
Issuance (Retirement) of Stock, Net	-18.311	2.365	0.778	0.582	0.771
Issuance (Retirement) of Debt, Net	-106.58	-4.584	3.555	53.776	37.348
Foreign Exchange Effects	-1.545	0.811	1.229	-1.058	-1.234
Net Change in Cash	-11.854	61.851	51.308	44.765	7.714

	Dec 2022	Jun 2022	Dec 2021	Jun 2021	Dec 2020
Net income/Starting Line	143.702	59.962	83.716	38.84	64.67
Cash From Operating Activities	196.225	134.9	160.112	83.183	133.146
Cash From Operating Activities	37.513	19.265	36.725	17.345	33.487
Amortization	2.703	1.361	2.601	1.135	2.008
Non-Cash Items	74.315	27.966	44.642	18.355	34.985
Cash Taxes Paid	29.146	14.588	21.742	11.505	9.705
Cash Interest Paid	6.796	3.524	7.305	3.455	6.025
Changes in Working Capital	-62.008	26.346	-7.572	7.508	-2.004
Cash From Investing Activities	-22.832	-11.363	-52.199	-40.441	-62.189
Capital Expenditures	-25.299	-11.811	-52.804	-40.711	-60.064
Other Investing Cash Flow Items, Total	2.467	0.448	0.605	0.27	-2.125
Cash From Financing Activities	-183.702	-99.078	-46.873	-30.648	-20.878
Financing Cash Flow Items	-6.796	-3.524	-7.305	-3.455	-6.025
Total Cash Dividends Paid	-52.015	-52.015	-37.349	-37.349	-19.186
Issuance (Retirement) of Stock, Net	-18.311	-19.126	2.365	2.504	0.778
Issuance (Retirement) of Debt, Net	-106.58	-24.413	-4.584	7.652	3.555
Foreign Exchange Effects	-1.545	-0.413	0.811	0.514	1.229
Net Change in Cash	-11.854	24.046	61.851	12.608	51.308

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

Leverage

1:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Raffles Medical Company profile

Track the Raffles Medical share price today and spot the best levels for profitable CFD trades

Raffles Medical Group Ltd is a full spectrum health services company founded in Singapore in 1976. The company served over 2 million clients in 2020 with operations in 14 cities across five countries. As with many other companies, Raffles Medical initially suffered greatly from closures enacted due to the coronavirus pandemic. The company was unable to offer any non-essential health services which form a large part of its revenue.

After an initial period of closures the company was able to devise new income streams through providing Covid testing to migrant workers and other travellers entering the Southeast Asian countries where they have operations. The company is currently the largest private health care services provider in Singapore.

Raffles Medical stock price was listed on the Singapore Stock Exchange mainboard on April 11, 1997 and trades under the ticker symbol BSL. Raffles Medical operates three primary business lines. The first is healthcare, which offers insurance services, pharmaceutical products and services as well as aftercare coverage for patients. The hospital division offers emergency and surgery services as well as medical devices for patient use. Finally the company has an active investment division, primarily dealing with the real estate holdings of the group.

The Raffles Medical (BSL) stock has traded within the 52-week range of S$0.75 - S$1.14 at an average volume of close to 53 million shares per day. The stock began 2021 at S$0.995 before dipping to a low of S$0.925 near the end of January and then rising steadily to S$1.09 by late March.

BSL has a market capitalisation of just over $2 billion Singapore dollars and posted a net income of S$65 million in 2020. Revenues increased to S$568 million in 2020, up 8.8 per cent from the previous year.

The latest BSL stock chart is updated on the SGX as well as on Capital.com. By accessing the live price chart on Capital.com you can view the Raffles Medical Group share price in real time.

You can trade BSL now with CFDs and open a long or short position, depending on whether you feel the price will rise or fall. CFDs allow you to profit from upward or downward fluctuations in the Raffles Medical (SGX) stock price at Capital.com. Track the BSL stock price and include this Singapore-founded multinational medical services company in your investment portfolio.

Industry:

Ambulance & Emergency Services

585 North Bridge Road
188770
SG

Income Statement

Annual
Quarterly

News

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024